Information Provided By:
Fly News Breaks for January 7, 2020
SYK
Jan 7, 2020 | 16:23 EDT
SunTrust analyst Kaila Krum initiated coverage of Stryker with a Hold rating and $217 price target. While the Wright Medical deal makes sense, sales rep attrition may be a near-term issue, Krum tells investors in a research note. Further, the analyst thinks Stryker's earnings performance "will be weighed down" in 2021.